BioSpace News Archive

Revenue increased 45% over the same period last year, growing to $1,118,512

Patent significantly expands Relmada intellectual property protection for d-methadone, a novel NMDA receptor antagonist, in key global market

Company Hosts Reception at AHRMM Booth Exploring How Technology Helps to Increase Safety and Efficiency, While Lowering Costs

Vaxart ended the quarter with cash and cash equivalents of $23.9 million compared to $17.5 million at March 31, 2018.

Jeffrey M. Stamps, R.Ph., Chairman and CEO of Remedi SeniorCare, announces the opening of the company’s newest Paxit® pharmacy in Plymouth, Michigan.

BioAmber Inc. has initiated a liquidation process pursuant to which offers will be solicited from liquidators and/or strategic buyers to proceed with the liquidation of the company’s assets or a recapitalization transaction with the goal of realizing the greatest value on behalf of the company’s creditors.

THC BioMed Intl Ltd. announces that it has developed a cannabis beverage that mimics alcohol in that the uplifting and energizing effects of the cannabis is felt by the consumer in a short period of time.

Jørgen Søberg Petersen, M.D., Ph.D., DMSc, MBA and Timothy Anderson to Join Board of Directors

Transaction to Advance Millendo’s Compelling Pipeline of Late-Stage Programs for Orphan Endocrine Diseases Including Prader-Willi Syndrome

PAVmed Inc. announced that the Company will report second quarter financial results on or before August 14, 2018 and host a conference call on Wednesday, August 22, 2018 at 4:30 p.m. Eastern time.